About Us  |  Contact Us
Butler Hospital
butler_leftnavImage_logo
Butler Hospital
 

 Support Research

Memory and Aging Program
Study - Genentech Crenezumab Research

What is the Genentech Crenezumab Study for Alzheimer's Disease?

This is a Phase II multicenter study evaluating the long-term safety and tolerability of the drug crenezumab in patients with mild-to-moderate Alzheimer's disease.

What is the purpose of the Genentech Crenezumab Study

To test long-term safety extension Phase II Studies ABE4869g and ABE4955g in patients with mild to moderate Alzheimer's Disease.

Eligibility

Patients who participated in and completed the ABE486g or ABE 4955g Phase I clinical trial are eligible to participate.

If you are interested in learning more about the Crenezumab study, please call (401) 455-6403 or send an e-mail to: memory@butler.org.

For information on other current research studies at Butler Hospital please click here.

Alzheimers Research Studies Butler Hospital, Providence, Rhode Island
Care New England
© 2016 Site Index | Disclaimer | Legal Notices | Talks Your Health